October 3, 2025

Glioblastomas affect much more than just the brain, scientists discover

October 3, 2025 / Research update / InnovateMed Author / glioblastoma

by Albert Einstein College of Medicine edited by Sadie Harley, reviewed by Robert Egan Editors’ notes A case of glioblastoma relapsed during immunotherapy. Credit: Yan Li et al, CC BY 4.0 Scientists at Montefiore Einstein Comprehensive Cancer Center (MECCC) and Albert Einstein College of Medicine have shown for the first time that glioblastoma—the deadliest form of brain cancer—affects not […]

Glioblastomas affect much more than just the brain, scientists discover Read More »

Diabetes drugs show promise for treatment of alcohol use disorder

October 3, 2025 / Research update / InnovateMed Author / diabetes drugs

by Ingrid Fadelli, Phys.org edited by Gaby Clark, reviewed by Robert Egan Editors’ notes Comparison of drug-target Mendelian randomization (DTMR) with randomized control trials (RCTs) (adapted from Chauquet et al. [90]). The design for a a hypothetical RCT that investigates the impact of GIPR/GLP1R agonists on alcohol consumption behaviors, liver health, and food preferences is compared to b

Diabetes drugs show promise for treatment of alcohol use disorder Read More »

FDA approves Tremfya for pediatric plaque psoriasis, active psoriatic arthritis

October 3, 2025 / Clinical Practice / InnovateMed Author / psoriatic arthritis

by Lori Solomon edited by Sadie Harley, reviewed by Andrew Zinin Editors’ notes The U.S. Food and Drug Administration has approved Johnson & Johnson’s Tremfya (guselkumab) for the treatment of plaque psoriasis and active psoriatic arthritis in children 6 years of age and older. The approval is for pediatric patients living with either moderate-to-severe plaque psoriasis, who are

FDA approves Tremfya for pediatric plaque psoriasis, active psoriatic arthritis Read More »

Acalculia: Why many stroke survivors struggle with numbers

October 3, 2025 / Clinical Practice / InnovateMed Author / stroke survivors

by Yael Benn, The Conversation edited by Robert Egan Editors’ notes Credit: CC0 Public Domain Numbers are all around us. In the morning, we wake up to an alarm that tells us it’s time to get out of bed. When deciding what to wear, we often check the temperature outside. We count out the vitamins or prescription

Acalculia: Why many stroke survivors struggle with numbers Read More »

Garbage-collecting immune cells can protect insulin production in pancreas

October 3, 2025 / Research update / InnovateMed Author / insulin production

by Marta Wegorzewska, Washington University in St. Louis edited by Gaby Clark, reviewed by Robert Egan Editors’ notes Researchers at WashU Medicine have discovered that certain immune cells in the pancreas, called macrophages, can protect insulin-producing cells and prevent Type 1 diabetes in mice. Shown is a macrophage (white) engulfing a dying insulin-producing cell (green) in the pancreas

Garbage-collecting immune cells can protect insulin production in pancreas Read More »

FDA’s approval of generic mifepristone receives pushback

October 3, 2025 / News update / InnovateMed Author / mifepristone

The typically rote process of generic drug approval at the Food and Drug Administration generated some negative attention Thursday after federal officials approved another generic version of the abortion pill mifepristone. Drugmaker Evita Solutions announced on its website that the Food and Drug Administration signed off on its low-cost form of the pill, which is approved to

FDA’s approval of generic mifepristone receives pushback Read More »

Introducing the ‘human repairome,’ a catalog of DNA ‘scars’ that may help define personalized cancer treatments

October 3, 2025 / Research update / InnovateMed Author / DNA scars

by The Spanish National Cancer Research Centre edited by Sadie Harley, reviewed by Robert Egan Editors’ notes Infographic about human repairome. Credit: @CireniaSketches / CNIO You can always be judged by your scars. This is the idea that sums up one of the new advances in basic and biomedical research published in the journal Science by the Spanish National Cancer

Introducing the ‘human repairome,’ a catalog of DNA ‘scars’ that may help define personalized cancer treatments Read More »

Vision therapy reverses concussion-related double and blurred vision, study finds

October 3, 2025 / Clinical Practice / InnovateMed Author / vision therapy

by Tracey Regan, New Jersey Institute of Technology edited by Stephanie Baum, reviewed by Andrew Zinin Editors’ notes Credit: Unsplash/CC0 Public Domain Nearly half of adolescents and young adults with lingering symptoms of concussion suffer from eye coordination disorders that cause double and blurred vision, headaches and difficulties concentrating. “These conditions make it hard to read books, work

Vision therapy reverses concussion-related double and blurred vision, study finds Read More »

Novel antibiotic targets IBD—and AI predicted how it would work before scientists could prove it

October 3, 2025 / Research update / InnovateMed Author / novel antibiotic

by McMaster University edited by Sadie Harley, reviewed by Robert Egan Editors’ notes Credit: Pixabay/CC0 Public Domain Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs at once: they not only discovered a brand-new antibiotic that targets inflammatory bowel diseases (IBD), but also successfully used a new type of AI to

Novel antibiotic targets IBD—and AI predicted how it would work before scientists could prove it Read More »

Allergic rhinitis, hearing loss linked to ADHD in children

October 3, 2025 / Clinical Practice / InnovateMed Author / ADHD, allergic rhinitis

by Elana Gotkine edited by Stephanie Baum, reviewed by Andrew Zinin Editors’ notes Hearing loss and allergic rhinitis are associated with attention-deficit/hyperactivity disorder (ADHD), with a stronger association seen in patients with both conditions than either one alone, according to a study published online Sept. 12 in the International Journal of Environmental Research and Public Health. Bo Ram Yang, Ph.D.,

Allergic rhinitis, hearing loss linked to ADHD in children Read More »